TNF-α convertase enzyme from human arthritis-affected cartilage: Isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-α

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4570-4579

  Patel, Indravadan R ^a   Attur, Mukundan G ^a   Patel, Rajesh N ^a   Stuchin, Steven A ^a   Abagyan, Ruben A ^b   Abramson, Steven B ^a,c   Amin, Ashok R ^a,c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; METALLOPROTEINASE; TUMOR NECROSIS FACTOR;

ARTHRITIS; ARTICLE; AUTOCRINE EFFECT; CARTILAGE CELL; CATALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; GENE ISOLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; NORTHERN BLOTTING; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAM PROTEINS; ARTHRITIS, RHEUMATOID; CARTILAGE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; ORGAN CULTURE TECHNIQUES; SEQUENCE ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032080801     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
2. Traccy, K. J,. and J. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491.
3. Higashi, N., N. Yoshizuka, A. Ohuchi, T. Osawa, and Y. Kobayashi. 1995. Involvement of inflammatory cytokines in a delayed-type hypersensitivity reaction. Cell. Immunol. 161:288.
4. Feldmann, M., F. M. Brennan, R. O. Williams, M. J. Elliott, and R. N. Maini. 1996. Cytokine expression and networks in rheumatoid arthritis rationale for anti-TNFα antibody therapy and its mechanism of action. J. Inflamm. 47:90.
5. Barbara, J., X. Van Ostade, and A. Lopez. 1996. Tumour necrosis factor-alpha (TNF-α): the good, the bad and potentially very effective. Immunol. Cell Biol. 74:434.
6. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317.
7. Baker, S. J., and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9.
8. William, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
9. Mori, L., S. Iselin, G. De Libero, and W. Lesslauer. 1996. Attenuation of collagen-induced arthritis in 55-kDaA TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J. Immunol. 157:3178.
10. Elliott, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Bijl, and J. N. Woody. 1994. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125.
11. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, M. B. Widmer, and C. M. Blosch. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 317:141.
12. Testa, V., G. Capasso, N. Maffulli, A. Sgambato, and P. R. J. Ames. 1994. Proteases and antiproteases in cartilage homeostasis. Clin. Orthop. Relat. Res. 308:79.
13. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood and K. Woolley. 1994. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 370:555.
14. Mohler, K. M., P. R. Sleath, J. N. Fitzner, D. P. Cerrettl, M. Alderson, S. S. Kerwar, D. S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, S. R. Kronheldm, M. Petersen, M. Gerhart, C. J. Kozlosky, C. J. March, and R. A. Black. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370:218.
15. Moss M., S.-L. Catherine Jin, M. E. Milla, W. Burkhart, H. Luke Carter, Wen-Ji Chen, W. C. Clay, J. R. Didsbury, D. Hassler, C. R. Hoffman, T. A. Kost, M. H. Lambert, M. A. Leesnitzer, P. McCauley, G. McGeehan, J. Mitchell, M. Moyer, G. Pahel, W. Rocque, L. K. Overton, F. Schoenen, T. Seaton, Jui-Lan Su, J. Warner, D. Willard, and J. D. Becherer. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α. Nature 385: 733.
16. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Bolanl, K. A. Schooley, M. Gerhart, R. Davis, J. N. Fitzner, R. S. Johnson, R. J. Paxton, C. J. March, and D. P. Cerretti. 1997. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature 385:729.
17. Williams, L. M., D. L. Gibbons, A. Gearing, R. N. Maini, M. Feldmann, and F. M. Brennan. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both P55 and P75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures. J. Clin. Invest. 97:2833.
18. Amin, A. R., P. Di Cesare, P. Vyas, M. G. Attur, E. Tzeng, T. R. Billiar, S. A. Stuchin, and S. B. Abramson. 1995. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J. Exp. Med. 182:2097.
19. Amin, A. R., M. G. Attur, R. N. Patel, G. D. Thakker, P. J. Marshall, J. Rediske, S. A. Stuchin, I. R. Patel, and S. B. Abramson. 1997. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. J. Clin. Inv. 99: 1231.
20. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387.
21. Whitham, S. E., G. Murphy, P. Angel, H. J. Rahmsdorf, B. J. Smith, A. Lyons, T. J. Harris, J. J. Reynolds, P. Herrlich, and A. J. Docherty. 1986. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem. J. 240:913.
22. Templeton, N. S., P. D. Brown, A. T. Levy, I. M. Margulies, L. A. Liotta, and W. G. Stetler-Stevenson. 1990. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res. 50:5431.
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
24. Goldring, M. B, J. R. Birkhead, L.-F. Suen, R. Yamin, S. Mizuno, J. Glowacki, J. L. Arbiser, and J. F. Apperley. 1994. Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94:2307.
25. Patel, I. R., P. Vyas, M. Attur, G. Thakker, S. B. Abramson, A. R. Amin. 1997. Cloning and expression of a functional, dimeric, multi-cofactor-requiring murine macrophage inducible nitric oxide synthase in bacteria-to-bacmid transposition-baculovirus system. Transgenics 2:161.
26. Abagyan, R. A., M. M. Totrov, and D. A. Kuznetsov. 1994. ICM, a new method for structure modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comp. Chem. 15:488.
27. Abagyan, R. A., and S. Batalov. 1997. Do aligned sequences share the same fold? J. Mol. Biol. 273::355.
28. 2 and IL-8. Proc. Assoc. Am. Phys. 110:1-8.
29. Wolfsberg, T. G., J. F. Bazan, C. P. Blobel, D. G. Myles, P. Primakoff, and J. M. White. 1993. The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications. Proc. Natl. Acad. Sci. USA 90:10783.
30. Gomis-Rüth, F. X., L. F. Kress, J. Kellermann, I. Mayr, X. Lee, R. Huber, and W. Bode. 1994. Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin. II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin. J. Mol. Biol. 239:513.
31. Gomis-Rüth, F. X., L. F. Kress, and W. Bode. 1993. First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. EMBO J. 12:4151.
32. Bode, W., F. X. Gomis-Ruth, and W. Stockler. 1993. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the "metzincins." FEBS Lett. 331:134.
33. Jongeneel, C. V., J. Bouvier, and A. Bairoch. 1989. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242:211.
34. Mallett, S., and A. N. Barclay. 1991. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today 12:220.
35. Naismith, J. H., and S. R. Sprang. 1996. Tumor necrosis factor receptor superfamily. J. Inflamm. 47:1.
36. Patschinsky, T., T. Hunter, F. S. Esch, J. A. Cooper, and B. M. Seton. 1982. Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 79:973.
37. Wasley, L. C., A. Rehemtulla, J. A. Bristol, and R. J. Kaufman. 1993. PACE/ furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway. J. Biol. Chem. 268:8458.
38. Wise, R. J., P. J. Barr, P. A. Wong, M. C. Kiefer, A. J. Brake, and R. J. Kaufman. 1990. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc. Natl. Acad. Sci. USA 87:9378.
39. Misumi, Y., K. Ohkubo, M. Sohda, N. Takami, K. Oda, Y. Ikehara. 1990. Intracellular processing of complement pro-C# and proalbumin is inhibited by rat alpha 1-protease inhibitor variant (Met352 - ARG) in transfected cells. Biochem. Biophvs. Res. Commun. 171:236.
40. Blanchette, F., R. Day, W. Dong, M. H. Laprise, and C. M. Dubois. 1997. TGFβ1 regulates gene expression of its own converting enzyme furin. J. Clin. Invest. 99:1974.
41. Stöcker, W., F. Grams, U. Baumann, P. Reinemer, F.-X. Gomis-Rüth, D. B. McKay, and W. Bode. 1995. The metzincins: topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4:823.
42. Woessner, J. F., Jr. 1994. The family of matrix metalloproteinases. Ann. NY Acad. Sci. 732:11.
43. Lotz, M., R. Terkeltaub, and P. M. Villiger. 1992. Cartilage and joint inflammation: regulatin of IL-8 expression by human articular chondrocytes. J. Immunol. 148:466.
44. McKie, N., T. Edwards, D. J. Dallas, A. Houghton, B. Stringer, R. Graham, G. Russell, and P. I. Croucher. 1997. Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes. Biochem. Biophys. Res. Commun. 230:335.
45. Ferguson, K. M., M. A. Lemmon, J. Schlessinger, and P. B. Sigler. 1995. Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell 83:1037.
46. Netzel-Arnett, S., A. Salari, U. B. Goli, and H. E. Van Wart. 1994. Evidence for a triple helix recognition site in the hemopexin-like domains of human fibroblast and neutrophil interstitial collagenases. Ann. NY Acad. Sci. 732:22.
47. Robace-Gallea, S., J.-M. Bruneau, H. Robbe, V. Morand, C. Capdevila, N. Bhatnagar, S. Chouaib, and S. Roman-Roman. 1997. Partial purification and characterization of a tumor recrosis factor-α converting activity. Eur. J. Immunol. 27:1275.
48. Lunn, C. A., F. Xuedong, B. Dalie, K. Miller, P. J. Zavodny, S. K. Narula, and D. Lundell. 1997. Purification of ADAM 10 from bovine spleen as a TNFα convertase. FEBS Lett. 400:333.
49. Gearing, A. J., P. Beckett, M. Christodolou, M. Churchill, J. M. Clements, M. Crimmin,. A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, et al. 1995. Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukocyte Biol. 57:774.
50. Huang, T. F., J. C. Holt, E. P. Kirby, and S. Niewiarowski. 1989. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry 28: 661.
51. Blobel, C. P. 1997. Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNFα and Notch. Cell 90:589.
52. Blobel, C. P., and J. M. White. 1992. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr. Opin. Cell Biol. 4:760.
53. Schlaak, J. F., I. Pfers, K. H. Meyer Zum Buschenfelde, and E. Marker-Hermann. 1996. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, reheumatoid arthritis and seronegative spondylarthropathies. Clin. Exp. Rheum. 14:155.
54. Hough, A.J. 1997. Pathology of osteoarthritis. In Arthritis and Allied Conditions: A Textbook of Rheumatology. W. J. Koopman, ed. Williams & Wilkins, Baltimore, MD., pp. 1945-1968.
55. Freije, J. M., I. Diez-Itza, M. Balbin, L. M. Sanchez, R. Blasco, J. Toliva, C. Lopez-Otin. 1994. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269:16766.